Misoprostol use in obstetrics and gynecology in Brazil, Jamaica, and the United States

被引:33
作者
Clark, S
Blum, J
Blanchard, K
Galvao, L
Fletcher, H
Winikoff, B
机构
[1] Populat Council, New York, NY 10017 USA
[2] Populat Council, Johannesburg, South Africa
[3] Populat Council, Sao Paulo, Brazil
[4] Univ W Indies, Mona, Jamaica
关键词
misoprostol; Cytotec; pregnancy; reproductive health;
D O I
10.1016/S0020-7292(01)00567-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To investigate current clinical use of misoprostol for the treatment of a range of reproductive health indications by providers in Brazil, Jamaica, and the United States. Methods: Using a 'snowball' sampling technique, we surveyed 228 gynecologists and obstetricians in Brazil (n = 123), Jamaica (n = 52), and the United States (n = 53). Results: Providers use misoprostol for labor induction (46%), postpartum hemorrhage (8%), intra-uterine fetal death (61%), cervical priming (21%), missed abortion (57%), and incomplete abortion (16%) as well as first and second trimester abortion induction (27% and 13%, respectively). Conclusions: There is considerable variation in the regimens used; moreover, the regimens commonly used in clinical practice often differ from those recommended in the medical literature. While misoprostol is art appealing alternative for many reproductive health indications in developing countries, the varied regimens and lack of registration raise critical medical and policy questions. C 2002 International Federation of Gynecology and Obstetrics. All rights reserved.
引用
收藏
页码:65 / 74
页数:10
相关论文
共 10 条
[1]   THE BRAZILIAN EXPERIENCE WITH CYTOTEC [J].
BARBOSA, RM ;
ARILHA, M .
STUDIES IN FAMILY PLANNING, 1993, 24 (04) :236-240
[2]   Misoprostol used alone for the termination of early pregnancy - A review of the evidence [J].
Blanchard, K ;
Winikoff, B ;
Ellertson, C .
CONTRACEPTION, 1999, 59 (04) :209-217
[3]  
BLANCHARD K, UNPUB OBSTET GYNECOL
[4]   Commercial availability of misoprostol and induced abortion in Brazil [J].
Costa, SH .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1998, 63 :S131-S139
[5]   The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management [J].
El-Refaey, H ;
Nooh, R ;
O'Brien, P ;
Abdalla, M ;
Geary, M ;
Walder, J ;
Rodeck, C .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2000, 107 (09) :1104-1110
[6]   Drug therapy: Misoprostol and pregnancy. [J].
Goldberg, AB ;
Greenberg, MB ;
Darney, PD .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) :38-47
[7]   WHO multicentre randomised trial of misoprostol in the management of the third stage of labour [J].
Gülmezoglu, AM ;
Villar, J ;
Ngoc, NTN ;
Piaggio, G ;
Carroli, G ;
Adetoro, L ;
Abdel-Aleem, H ;
Cheng, LN ;
Hofmeyr, GJ ;
Lumbiganon, P ;
Unger, C ;
Prendiville, W ;
Pinol, A ;
Elbourne, D ;
El-Refaey, H ;
Schulz, KF .
LANCET, 2001, 358 (9283) :689-695
[8]  
Hofmeyr GJ, 1998, BRIT J OBSTET GYNAEC, V105, P971
[9]   A multicentre randomized controlled trial of oral misoprostol and i.m. syntometrine in the management of the third stage of labour [J].
Ng, PS ;
Chan, ASM ;
Sin, WK ;
Tang, LCH ;
Cheung, KB ;
Yuen, PM .
HUMAN REPRODUCTION, 2001, 16 (01) :31-35
[10]  
SANTOSBUELGA C, 1996, POLYPHENOLS COMMUNIC, V1, P9